RaySearch Laboratories AB has entered into an exclusive distribution agreement with AlphaXRT based in Sydney, Australia and Auckland, New Zealand. 

Medical physicists met in Denver, Colo., March 15-18 for the American Association of Physicists in Medicine (AAPM) Spring Clinical Meeting, hosted at the Denver Marriott Tech Center. The meeting focused on helping medical physicists with the integration of emerging technologies into the clinical environment. Mirada Medical demonstrated its comprehensive suite of advanced deformable image registration (DIR) software tools to meeting attendees. The company utilizes its scientifically advanced DIR algorithms to provide practical tools to support treatment planning.

ProTom International Inc has received 510(k) clearance for its Radiance 330 Proton Therapy System. The Radiance 330 is a compact, modular and more affordable proton beam delivery system for the treatment of patients with cancer. The system delivers extremely focused, conformal, scanned proton beams that destroy tumors while sparing nearby healthy tissue and anatomical structures.

VuComp Inc. debuted its automated breast density measurement technology, M-Vu Breast Density, at NCoBC, March 15-19 in Las Vegas. Clinical studies have shown that dense breasts can make breast cancer detection in a mammogram more difficult by potentially masking malignant masses. Because of this, radiologists classify breast density into four categories established by the American College of Radiology’s Breast Imaging Reporting and Data System (BI-RADS) standard.

Mynx Ace Vascular Closure Device

Fujifilm Medical Systems U.S.A., Inc. and Fujifilm SonoSite Inc. showcased its women’s health care solutions at the National Consortium of Breast Center Meeting in Las Vegas, March 15-19. The NCoBC brings together medical and industry professionals from around the globe to network, learn and share ideas, methodologies and treatment options that improve quality of care and outcome for patients diagnosed with breast diseases.

Neuraceq (florbetaben F-18 injection)

The U.S. Food and Drug Administration (FDA) has approved a third beta-amyloid plaque positron emission tomography (PET) imaging radiotracer to identify Alzheimer’s disease. The FDA’s approval of Piramal Imaging’s Neuraceq (florbetaben F-18 injection) comes four weeks after receiving marketing authorization in Europe. 

Medical industry veteran Walt Cebulski died at his home in Foresthill, Calif., on Jan. 24 after a brief fight with cancer. He was 58.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now